JP2012502884A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502884A5 JP2012502884A5 JP2011526360A JP2011526360A JP2012502884A5 JP 2012502884 A5 JP2012502884 A5 JP 2012502884A5 JP 2011526360 A JP2011526360 A JP 2011526360A JP 2011526360 A JP2011526360 A JP 2011526360A JP 2012502884 A5 JP2012502884 A5 JP 2012502884A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- compound
- pharmaceutically acceptable
- acceptable salt
- intervening substituent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9747008P | 2008-09-16 | 2008-09-16 | |
| US61/097,470 | 2008-09-16 | ||
| PCT/CA2009/001302 WO2010037207A1 (en) | 2008-09-16 | 2009-09-16 | Selective glycosidase inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012502884A JP2012502884A (ja) | 2012-02-02 |
| JP2012502884A5 true JP2012502884A5 (enExample) | 2012-07-12 |
Family
ID=42072983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526360A Pending JP2012502884A (ja) | 2008-09-16 | 2009-09-16 | 選択的グリコシダーゼ阻害剤およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110301217A1 (enExample) |
| EP (1) | EP2344452A4 (enExample) |
| JP (1) | JP2012502884A (enExample) |
| AU (1) | AU2009299073B2 (enExample) |
| CA (1) | CA2737267A1 (enExample) |
| WO (1) | WO2010037207A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2436687A1 (en) * | 2005-03-01 | 2012-04-04 | Simon Fraser University | Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| EP2057171A4 (en) | 2006-08-31 | 2010-04-21 | Univ Fraser Simon | SELECTIVE GLYCOSIDASE INHIBITORS AND APPLICATIONS THEREOF |
| JP5687194B2 (ja) * | 2008-08-01 | 2015-03-18 | サイモン フレイザー ユニバーシティ | 選択的グリコシダーゼインヒビターおよびその使用 |
| US9120781B2 (en) | 2010-05-11 | 2015-09-01 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| SG189174A1 (en) * | 2010-10-11 | 2013-05-31 | Biogen Idec Internat Neuroscience Gmbh | Human anti-tau antibodies |
| US8901087B2 (en) | 2010-11-08 | 2014-12-02 | Merck Sharp & Dohme Corp. | Selective glycosidase inhibitors and uses thereof |
| US8933040B2 (en) | 2010-11-08 | 2015-01-13 | Craig A. Coburn | Selective glycosidase inhibitors and uses thereof |
| TW201249848A (en) | 2010-11-08 | 2012-12-16 | Merck Sharp & Dohme | Selective glycosidase inhibitors and uses thereof |
| LT2655388T (lt) | 2010-12-23 | 2016-11-10 | Alectos Therapeutics Inc. | Selektyvieji glikozidazės inhibitoriai ir jų panaudojimas |
| GB201103526D0 (en) * | 2011-03-02 | 2011-04-13 | Summit Corp Plc | Selective glycosidase inhibitors and uses thereof |
| US8927507B2 (en) | 2011-03-24 | 2015-01-06 | Ernest J. McEachern | Selective glycosidase inhibitors and uses thereof |
| US9718854B2 (en) | 2011-03-31 | 2017-08-01 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| US9199949B2 (en) | 2011-06-27 | 2015-12-01 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| US9701693B2 (en) | 2011-06-27 | 2017-07-11 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| WO2013000084A1 (en) | 2011-06-27 | 2013-01-03 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| KR102108586B1 (ko) | 2012-05-08 | 2020-05-07 | 머크 샤프 앤드 돔 코포레이션 | 투과성 글리코시다제 억제제 및 그의 용도 |
| WO2014032185A1 (en) | 2012-08-31 | 2014-03-06 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
| WO2014032188A1 (en) * | 2012-08-31 | 2014-03-06 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
| CA2890115A1 (en) | 2012-10-31 | 2014-05-08 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
| WO2024083820A1 (en) | 2022-10-18 | 2024-04-25 | Institut National de la Santé et de la Recherche Médicale | Method and composition for determining the level of o-glcnacylation in horses |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8900719D0 (en) * | 1989-01-13 | 1989-03-08 | Nycomed As | Compounds |
| US5451679A (en) * | 1994-03-08 | 1995-09-19 | G. D. Searle & Co. | 2-chloro and 2-bromo derivatives of 1,5-iminosugars |
| FR2817472B1 (fr) * | 2000-12-06 | 2003-01-03 | Oreal | Composition de teinture d'oxydation a base de 1-(4-aminophenyl)pyrrolidines substituees au moins en position 2 et 3 et procede de teinture de mise en oeuvre |
| WO2003008379A1 (en) * | 2001-06-08 | 2003-01-30 | Mitsubishi Chemical Corporation | Azasugar compounds |
| CA2553866A1 (en) * | 2004-01-20 | 2005-08-11 | The Scripps Research Institute | Treatment of degenerative cartilage conditions in a mammal with glycosi dase inhibitors |
| EP2436687A1 (en) * | 2005-03-01 | 2012-04-04 | Simon Fraser University | Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| WO2007067515A2 (en) * | 2005-12-05 | 2007-06-14 | Academia Sinica | Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis therapeutics |
-
2009
- 2009-09-16 EP EP20090817127 patent/EP2344452A4/en not_active Withdrawn
- 2009-09-16 AU AU2009299073A patent/AU2009299073B2/en not_active Ceased
- 2009-09-16 WO PCT/CA2009/001302 patent/WO2010037207A1/en not_active Ceased
- 2009-09-16 CA CA2737267A patent/CA2737267A1/en not_active Abandoned
- 2009-09-16 US US13/119,362 patent/US20110301217A1/en not_active Abandoned
- 2009-09-16 JP JP2011526360A patent/JP2012502884A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014524911A5 (enExample) | ||
| JP2014501740A5 (enExample) | ||
| JP2015534991A5 (enExample) | ||
| JP2011529858A5 (enExample) | ||
| JP2011529857A5 (enExample) | ||
| JP2010501598A5 (enExample) | ||
| WO2008025170B1 (en) | Selective glycosidase inhibitors and uses thereof | |
| RU2013134345A (ru) | Селективные ингибиторы гликозидазы и их применение | |
| JP6243472B2 (ja) | カゼインキナーゼ１デルタ（ｃｋ１デルタ）阻害剤 | |
| JP6218260B2 (ja) | Ｊａｋ阻害剤としてのアミノピリミジニル化合物 | |
| Zhi et al. | Hybrid antibacterials. DNA polymerase− topoisomerase inhibitors | |
| Bagdanoff et al. | Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders | |
| RU2757218C2 (ru) | Аминопиразолы в качестве селективных ингибиторов янус-киназы | |
| Zhi et al. | Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth | |
| JP2013541596A5 (enExample) | ||
| Patel et al. | Synthesis of potential antitubercular and antimicrobial s-triazine-based scaffolds via Suzuki cross-coupling reaction | |
| WO2003076437A1 (de) | Cdk inhibitorische 2-heteroaryl-pyrimidine, deren herstellung und verwendung als arzneimittel | |
| JP5250553B2 (ja) | ２−置換―６−ヘテロ環ピリミドン誘導体 | |
| RU2014102232A (ru) | Селективные ингибиторы гликозидазы и их применение | |
| RU2015120556A (ru) | Ингибиторы гликозидаз и их применения | |
| JP2004505973A (ja) | ブラジキニンアンタゴニストとしての１，４−ジヒドロピリジン類 | |
| CA2545092A1 (en) | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity | |
| Suresh Kumar et al. | Synthesis and pharmacological evaluation of novel 4-isopropylthiazole-4-phenyl-1, 2, 4-triazole derivatives as potential antimicrobial and antitubercular agents | |
| MX2013015085A (es) | N-(6-((2r,3s)-3,4-dihidroxibutan-2-iloxi)-2-(4-fluorobenciltio)pi rimidin-4-il)-3-metilacetidina-1-sulfonamida como modulador del receptor de quimiocina. | |
| Krishna et al. | Synthesis and antimicrobial assessment of novel coumarins featuring 1, 2, 4-oxadiazole |